Telomir Pharmaceuticals (TELO) Cash from Financing Activities (2023 - 2025)
Telomir Pharmaceuticals (TELO) recorded Cash from Financing Activities of $1.16 million in Q4 2025, up 11.7% from $1.04 million a year earlier but down 84.6% from the prior quarter.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Cash from Financing Activities (2023 - 2025) Analysis & Trends
For FY2025, Telomir Pharmaceuticals reported Cash from Financing Activities of $9.71 million, up 53.2% from FY2024.
- Annual Cash from Financing Activities has increased for three straight years, with a three-year compound annual growth rate of 174.4% (FY2022 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $6.34 million in FY2024 (+64.1%), $3.86 million in FY2023 (+721.1%) and $470,080 in FY2022.
- Quarterly Cash from Financing Activities has ranged from -$46,909 in Q3 2024 to $7.5 million in Q3 2025 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in three of the last four quarters, with growth averaging 200.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Telomir Pharmaceuticals | 82.53 Mn | 82.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | -46,909.00 |
| Jun 30, 2024 | 132,438.00 |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 46,399.00 |
| Mar 31, 2023 | 736,127.00 |
API Access
Telomir Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();